Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction (Q24187850)

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Consequences on gonadotrophin secretion of an early discontinuation of gonadotrophin-releasing hormone agonist administration in short-term protocol for in-vitro fertilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Withdrawal of GnRH agonist decreases oestradiol and VEGF concentrations in high responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

A randomized prospective study on the effect of short and long Buserelin treatment in women with repeated unsuccessful in vitro fertilization (IVF) cycles due to inadequate ovarian response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Effect of halving the daily dose of triptorelin at the start of ovarian stimulation on hormone serum levels and the outcome of in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Effect of delayed initiation of gonadotropin in luteal long protocol on in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Ovarian response and outcome of in-vitro fertilization in patients treated with gonadotrophin-releasing hormone analogues in different phases of the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

A comparison between a standard and reduced dose of D-Trp-6-luteinizing hormone-releasing hormone administered after pituitary suppression for in-vitro fertilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Early cessation of triptorelin in in vitro fertilization: a double-blind, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro ferti

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization–embryo transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

The evaluation of a new 7-day gonadotropin-releasing hormone agonist protocol in the controlled ovarian hyperstimulation for in vitro fertilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Efficacy of low-dose hCG in late follicular phase in controlled ovarian stimulation using GnRH agonist protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

GnRH-agonist induced depressive and anxiety symptoms during in vitro fertilization-embryo transfer cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Comparison of short versus long-term leuprolide acetate--human menopausal gonadotrophin hyperstimulation in in-vitro fertilization patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Comparison of clinical efficacy between a single administration of long-acting gonadotrophin-releasing hormone agonist (GnRHa) and daily administrations of short-acting GnRHa in in vitro fertilization-embryo transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Prolonging GnRH-agonist to achieve ovarian suppression does not compromise the results of a long protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

A prospective randomized comparison between long and discontinuous-long protocols of gonadotropin-releasing hormone agonist for in vitro fertilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Prospective randomized study of D-Trp6-LHRH versus buserelin in long desensitization protocols for medically assisted conception cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Premature progesterone rise negatively correlated with live birth rate in IVF cycles with GnRH agonist: an analysis of 2,566 cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilizatio

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Clinical outcome of one-third-dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Relationship between gonadotropin releasing hormone agonist dosage and in vitro fertilization outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

The effect of the duration of GnRH-agonist down regulation before ovarian stimulation on the biological and clinical outcome after intracytoplasmic sperm injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Comparative trial between an ultra-short and long protocol of luteinizing hormone-releasing hormone agonist for ovarian stimulation in in-vitro fertilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Timing oocyte collection in GnRH agonists down-regulated IVF and ICSI cycles: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

The use of long- and short-acting forms of gonadotrophin-releasing hormone analogues in women undergoing oocyte donation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in-vitro fertilization outcome in normo-ovulatory women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

A controlled ovarian hyperstimulation regimen involving intermittent gonadotropin administration with a "short" protocol of gonadotropin releasing hormone agonist for in vitro fertilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Ovarian stimulation with buserelin/HMG/HCG: prospective randomized study of short versus long protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Evaluation of two gonadotropin-releasing hormone (GnRH) analogues (leuprolide and buserelin) in short and long protocols for assisted reproduction techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Effect of female age on the diagnostic categories of infertility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Gonadotrophin-releasing hormone-antagonists vs long agonist in in-vitro fertilization patients with polycystic ovary syndrome: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Hypersecretion of luteinising hormone, infertility, and miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

The duration of pituitary suppression by means of intranasal gonadotropin hormone-releasing hormone analogue administration does not influence the ovarian response to gonadotropin stimulation and success rate in a gamete intrafallopian transfer (GIF

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

[Prospective randomised study of long versus short agonist protocol with poor responder patients during in vitro fertilization]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Randomized, prospective trial of leuprolide acetate and conventional superovulation in first cycles of in vitro fertilization and gamete intrafallopian transfer.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

The Lupron screening test: tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

The effect of gonadotropin-releasing hormone agonist on the ovarian response and in vitro fertilization results in polycystic ovarian syndrome: a prospective study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Leuprolide acetate-prepared in vitro fertilization-gamete intrafallopian transfer cycles: efficacy versus controls and cost analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Comparison of short 7-day and prolonged treatment with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilization program.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Should gonadotropin-releasing hormone down-regulation therapy be routine in in vitro fertilization?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Profound luteinizing hormone suppression after stopping the gonadotropin-releasing hormone-agonist leuprolide acetate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Relationship of timing of agonist administration in the cycle phase to the ovarian response to gonadotropins in the long down-regulation protocols for assisted reproductive technologies.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

A novel method of ovarian stimulation for in vitro fertilization: bromocriptine-rebound method.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

A randomized prospective study of early follicular or midluteal initiation of long protocol gonadotropin-releasing hormone in an in vitro fertilization program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Hormonal changes induced by short-term administration of gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Adjuvant leuprolide in normal, abnormal, and poor responders to controlled ovarian hyperstimulation for in vitro fertilization/gamete intrafallopian transfer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Endocrine profiles and luteal function during GnRH-analogue/HMG therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Combined treatment with gonadotrophin releasing hormone agonist and gonadotrophins in poor responders to hyperstimulation for in vitro fertilization (IVF): clinical and endocrine results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Bias in meta-analysis detected by a simple, graphical test. Experts' views are still needed

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Fertility (update): summary of NICE guidance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

The dynamics of endometrial growth and the triple layer appearance in three different controlled ovarian hyperstimulation protocols and their influence on IVF outcomes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021

Which luteal phase support is better for each IVF stimulation protocol to achieve the highest pregnancy rate? A superiority randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006919.PUB4

7 January 2021